TickerFacts.

Elicio Therapeutics, Inc. (ELTX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2022-12-31
$1.19M2020-12-31: $1.19M2021-12-31: $433.0K2022-12-31: $0$0
2020-12-31 Cost of Revenue (USD) 2022-12-31
Period endedCost of RevenueChange YoYSource filing
2022-12-31$0-100.0%2023-03-17, From 2022-01-01
2021-12-31$433.0K-63.6%2023-03-17, From 2021-01-01
2020-12-31$1.19Mn/a2022-03-30, From 2020-01-01